Abstract
Background:
Polycystic ovary syndrome (PCOS) is a complex endocrine disorder affecting ≈8% to 13% of women of reproductive age. PCOS has multifaceted effects that extend beyond reproductive health. Women with PCOS are at an elevated risk for various metabolic conditions, including obesity, type 2 diabetes, and cardiovascular disease, as well as psychological challenges, such as anxiety, depression, and reduced quality of life. This systematic review examined the effectiveness of lifestyle interventions, including dietary, exercise, and behavioral modifications, in improving reproductive outcomes, mental well-being, and quality of life in women with PCOS.
Methods:
A comprehensive search was conducted using MEDLINE, EMBASE, Cochrane Library, and Web of Science databases, identifying observational and interventional studies published in English through December 2022. Studies were evaluated for methodological quality and categorized according to the type of lifestyle intervention and outcome measures.
Results:
Of the 24 studies reviewed, with 16 focusing on reproductive outcomes, 4 on quality of life, and 4 on combined outcomes, encompassing 1373 participants with the mean age in the included studies ranged from 21.7 to 36.5 years. Dietary modifications, either alone or in combination with exercise, resulted in significant improvements in reproductive health, including a 5% reduction in body weight (P < .001), increased menstrual regularity, higher pregnancy rates, and decreased testosterone levels (P < .01). Exercise interventions further contributed to positive outcomes; a 20-week exercise program improved ovulation rates by 49.1% and significantly reduced testosterone and free androgen indices (P < .001). In addition, structured exercise programs increased menstrual regularity by 60% and reduced body mass index and testosterone levels.
Conclusion:
This review underscores the efficacy of integrated lifestyle interventions, including dietary, exercise, and behavioral approaches, in improving reproductive health, psychological well-being, and quality of life in women with PCOS. These findings highlight the potential of comprehensive nonpharmacological management strategies to address the multifaceted health challenges posed by PCOS. Future research should prioritize long-term studies to assess sustained outcomes and examine personalized intervention strategies that account for the clinical diversity and heterogeneity of PCOS presentations.
Keywords: dietary, exercise, intervention, obesity, quality of life, reproductive health
1. Introduction
Polycystic ovary syndrome (PCOS) is a prevalent endocrine and reproductive disorder characterized by hyperandrogenism, polycystic ovarian morphology, and ovulatory dysfunction, affecting an estimated 6% to 10% of women of reproductive age.[1] This condition is frequently accompanied by a spectrum of metabolic disturbances, such as insulin resistance, obesity, dyslipidemia, and a heightened risk of cardiovascular disease, which collectively amplify its health impact.[2–5] In addition, PCOS is frequently accompanied by a profound impact on self-esteem, body image, and overall mental well-being.[3] While the precise pathogenesis of PCOS remains incompletely understood, genetic factors, disruptions in adipokines, proteins secreted by adipose tissue with roles in metabolic regulation, and inflammatory mediators are emerging as significant contributors to its development and progression.[6,7]
The complexity of PCOS, marked by its metabolic, reproductive, and psychological manifestations, necessitates a comprehensive management strategy.[8,9] Lifestyle interventions, including dietary, exercise, and behavioral modifications, are increasingly recognized as foundational components in the management of PCOS. These nonpharmacological approaches have shown potential benefits in improving reproductive health, insulin sensitivity, weight control, and overall quality of life.[10–13] However, despite promising findings, the evidence remains varied regarding the effectiveness of specific intervention types and combinations, particularly in terms of long-term outcomes.
A gap persists in synthesizing robust, comparative evidence on how lifestyle interventions, whether as standalone or combined approaches, address the diverse challenges of PCOS. This systematic review aimed to critically evaluate the current literature on dietary, exercise, and behavioral interventions in PCOS, with a focus on reproductive, psychological, and quality-of-life outcomes, to provide a clearer understanding of their effectiveness and inform future research directions.
2. Materials and methods
2.1. Study design
This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines[14] to ensure transparency and rigor in the review process. The population, intervention, comparator, outcomes, and study design framework were used to define the eligibility criteria and guide the selection of studies. All steps, including study selection, data extraction, and bias assessment, were documented and independently verified by the reviewers.
2.2. Eligibility criteria
Studies were considered eligible for inclusion if they examined women of reproductive age diagnosed with PCOS, as defined by standardized criteria, such as the Rotterdam, National Institutes of Health (NIH), or Androgen Excess and PCOS society criteria. This review focused on studies evaluating the impact of lifestyle interventions, including dietary modifications, exercise programs, and behavioral therapy, on outcomes related to reproductive health, psychological well-being, and quality of life. Observational and interventional study designs, such as randomized controlled trials (RCTs), nonrandomized trials, and cohort studies, were included to provide a comprehensive perspective.
To ensure the relevance and reliability of the data, only studies published in English with quantifiable outcome measures were included. Articles that lacked full-text availability, focused solely on pharmacological or surgical treatments, or employed nonstandard diagnostic criteria for PCOS were excluded. In addition, systematic reviews, ongoing trials, and studies with insufficient methodological details or a significant risk of bias were omitted.
2.3. Search strategy
A comprehensive search was conducted across multiple databases, including MEDLINE, EMBASE, Cochrane Library, and Web of Science, for studies published up to December 2022. Keywords and medical subject heading terms related to “PCOS,” lifestyle interventions, “diet,” exercise, “behavioral therapy,” reproductive health, “psychological health,” and “quality of life” were used. Reference lists of the included studies and gray literature were manually searched to identify additional relevant articles.
2.4. Study selection
Two independent reviewers screened the titles and abstracts to identify eligible studies. Full-text articles were reviewed based on inclusion and exclusion criteria. Any discrepancies between the reviewers were resolved through discussion or consultation with a third reviewer.
2.5. Assessment of bias
The risk of bias within each included study was assessed using the Cochrane Risk of Bias 2 tool.[15] This framework focuses on 5 domains: bias arising from the randomization process, deviations from intended interventions, missing outcome data, outcome measurement, and selection of the reported result. Each domain was rated as “low risk,” “some concerns,” or “high risk” based on signaling questions, and an overall risk of bias rating was assigned to each study.
To further minimize bias in the systematic review process, we addressed publication bias by conducting an extensive search of gray literature and manually reviewing reference lists to capture relevant unpublished studies. Selection bias at the review level was mitigated by following predefined inclusion criteria, ensuring a systematic and comprehensive approach for study selection. Two independent reviewers conducted all assessments and discrepancies were resolved through discussion or consultation with a third reviewer to enhance consistency and reliability.
2.6. Data extraction and synthesis
Data extraction was performed independently by 2 reviewers and included study characteristics (author, year, and design), participant demographics (sample size, age, and body mass index [BMI]), intervention details, outcomes assessed, and key findings. The extracted data were tabulated and qualitatively synthesized to highlight patterns in outcomes across dietary, exercise, and behavioral interventions.
2.7. Handling heterogeneity
Owing to the heterogeneity in study designs, interventions, and outcomes, a narrative synthesis approach was employed. This allowed for the integration of findings across diverse methodologies while accounting for variations in study populations and intervention protocols.
2.8. Ethical considerations
As this study involved a review of published literature, no ethical approval was required.
3. Results
3.1. Search results
The sequence of the identification and screening processes is displayed in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram (Fig. 1); a total of 764 publications were retrieved. Records were identified from 4 main databases: PubMed (n = 558), Cochrane (n = 12), Controlled Trials Register (n = 37), and EMBASE (n = 84). Other methods and sources for the identification of studies were the Web of Science (n = 36) relevant journals such as the Lancet and the New England Journal of Medicine (n = 7). More articles were found by manually searching and looking up references from the identified studies (n = 12).
Figure 1.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagrams for search strategy process.
The Rayyan online tool[16] was used to assess duplication, and (n = 258) duplicate articles were excluded. For the remaining identified research (n = 488 articles), an automated filter for the database, by using filter boxes such as study design (for RCTs, clinical trials, and observational studies) and age group, was used to narrow the search to relevant articles that met the inclusion criteria, by which a total of 372 articles were excluded. The title and abstract were selected and evaluated (n = 116), and, accordingly, another 86 articles were eliminated (n = 65) by title and (n = 21) by abstract evaluation.
After excluding publications based on the title or abstract, 30 full-text articles were extracted for a more thorough analysis. Following full-text screening, another 6 articles were excluded because they did not meet the eligibility criteria. The remaining 24 articles were deemed eligible for inclusion, and their methodological quality was assessed with the results reported in this review.
3.2. Characteristics of the included studies
In this systematic review, a total of 24 articles composed of 1373 participants, which were found to be relevant to the review question and meeting the inclusion criteria, were evaluated (Table 1) with a mean age of the participants, in the included studies, ranging between 21.7 ± 2.3 and 36.5 years. Four studies[17–20] displayed age as a range rather than a mean, while only 1 study did not state age.[21] As there is no time limitation, these articles were published from 1992 to 2022.
Table 1.
Overview of the included studies.
Author | Study design | Sample size | Characteristics of the participants | Intervention | Outcome | ||
---|---|---|---|---|---|---|---|
Age, y | BMI, kg/m² | Diagnosis | |||||
Kiddy et al[21] | Within group comparison | 24 | Not stated | 34.1 ± 4.9 | Pelvic USG Clinical and biochemical hyperandrogism |
Diet | Reproductive health |
Moran et al[30] | RCT | 45 | 33 ± 0.84 | 37.4 ± 1.24 | Clinical and/or biochemical hyperandrogenism | Diet | Reproductive health |
Stamets et al[31] | RCT (pilot) | 35 | Intervention: 29 ± 4 Control: 26 ± 4 |
Intervention: 38 ± 4 Control: 37 ± 5 |
Clinical and unexplained elevated circulating T levels | Diet | Reproductive health |
Bruner et al[41] | RCT (pilot) | 12 | 28.4 ± 2.7 32.3 ± 1 |
36.6 | Rotterdam criteria | Exercise + behavioral management | Reproductive health |
Vigorito et al[25] | RCT | 90 | Intervention: 21.7 ± 2.3 Control: 21.9 ± 1.9 |
Intervention: 29.3 ± 2.9 Control: 29.4 ± 3.5 |
ESHRE/ASRM | Exercise | Reproductive health |
Thomson et al[26] | RCT | 94 | 29.3 ± 0.68 | 36.1 ± 4.8 | Rotterdam criteria | Diet + exercise | Reproductive health |
Palomba et al[22] | Non-RCT | 40 | Intervention: 26.8 ± 5.1 Control: 25.8 ± 4.5 |
Intervention: 33.1 ± 1.3 Control: 33.2 ± 1.4 |
Rotterdam ESHRE/ASRM/NIH | Exercise | Reproductive health |
Kordi et al[32] | RCT | 24 | 22.7 ± 3.77 | 27.53 ± 5.02 | Trans-vaginal U/S | Exercise | Reproductive health |
Nybacka et al[17] | RCT | 57 | 18–40 yr | >27 kg/m2 | Rotterdam consensus | Diet | Reproductive health |
De Frène et al[24] | Prospective longitudinal within-patient study | 31 | 29 yr | ≥25 kg/m² 33.74 |
Rotterdam consensus | Diet + exercise + behavioral management | Quality of life |
Turan et al[35] | RCT | 32 | 24.45 ± 2.8 yr | Intervention: 14, 21.8 ± 1.0 Control: 16, 21.9 ± 1.1 |
ESHRE/ASRM | Exercise | Reproductive health |
Almenning et al[37] | RCT (pilot) | 31 | 27.2 ± 5.5 yr | 26.7 ± 6.0 | ESHRE/ASRM | Exercise | Reproductive health |
Stefanaki et al[40] | RCT | 23 | Intervention: 23.4 ± 4.62 Control: 28.3 ± 7.20 |
Intervention: 21.53 ± 2.15 Control: 23.7 ± 4.4 |
Rotterdam definition | Behavioral management | Quality of life |
Ramos et al[27] | Non-RCT case-control study | 124 | Intervention: 27.8 ± 5.34 Control: 29.74 ± 5.26 |
PCOS: 27.91 ± 5.51 Control: 25.99 ± 5.49 |
Rotterdam consensus | Exercise | Reproductive health Quality of life |
Vizza et al[33] | RCT | 15 | 27 | 37.8 | Not mentioned | Exercise | Reproductive function, psychological, and quality of life |
Deepthi et al[19] | Within group RCT | 30 | 18–25 yr | 26.11 kg/m2 | Not mentioned | Exercise | Quality of life |
Vasheghani-Farahani et al[38] | RCT | 40 | Control: 29 ± 5.39 Exercise: 27.7 ± 4.2 |
Control: 25.7 ± 2.15 Exercise: 28.8 ± 5.88 |
Rotterdam criteria | Exercise | Reproductive health |
Mani et al[28] | RCT | 161 | 33.4 ± 7.6 | Control = 33.2 (6.2) Intervention = 34.2 (7.2) |
ESHRE/ASRM | Behavioral management | Quality of life Reproductive health Psychological health |
Costa et al[20] | RCT | 27 | 18–34 yr | 25 and 39.9 kg·m−2 | Rotterdam criteria | Exercise | Quality of life |
Oberg et al[18] | RCT | 68 | 18–40 yr | ≥27 | Rotterdam PCOS criteria | Behavioral management | Reproductive health |
Cochrane et al[23] | Quasi-experimental | 15 | Intervention: 30.1 ± 4.6 Control: 37.5 ± 4.0 |
>28.6 | Not mentioned | Exercise + diet | Reproductive health |
Liu et al[29] | RCT | 296 | Intervention: 31.79 ± 3.38 Control: 32.31 ± 3.79 |
Intervention: 27.50 ± 0.24 Control: 27.63 ± 0.28 |
Modified Rotterdam criteria | Diet + exercise | Reproductive health |
Benham et al[39] | RCT | 60 | 29.2 ± 4.7 yr | 31.4 ± 8.4 kg/m2 | Rotterdam criteria | Exercise | Reproductive health |
D’souza et al[34] | RCT | 30 | Intervention: 24.26 ± 3.84 Control: 24.20 ± 3.54 |
23.39 ± 6.16 Not stated for control |
Not mentioned | Diet + exercises + behavioral management | Reproductive health Quality of life |
ASRM = American Society of Reproductive Medicine, BMI = body mass index, ESHRE = European Society of Human Reproduction and Embryology, NIH = National Institutes of Health, PCOS = polycystic ovary syndrome, RCT = randomized controlled trial, U/S = United States, USG = ultrasound sonography.
The studies varied considerably in their designs, populations, interventions, and reported outcomes, reflecting the complex and multifaceted nature of managing PCOS through lifestyle interventions. The included studies showed heterogeneity in several key areas. The study designs ranged from RCTs (19 studies), nonrandomized,[22] and quasi-experimental studies,[23] with varying levels of methodological rigor.[19,21,24]
Although most of the research had small to medium sample sizes ranging from 15 to 68 participants, on the other hand, 4 studies had larger sample sizes of 90, 94, 124, 161, and 296 women,[25–29] respectively. PCOS was diagnosed according to the Rotterdam criteria in 11 articles; European Society of Human Reproduction and Embryology (ESHRE)/American Society of Reproductive Medicine (ASRM) was used to establish the diagnosis in 4 studies. Palomba et al[22] used 3 criteria (Rotterdam ESHRE/ASRM/NIH, ASRM, and NIH). Clinical and biochemical hyperandrogenism of the pelvic ultrasound sonography were considered as diagnostic methods by Kiddy et al,[21] Moran et al,[30] Stamets et al,[31] and Kordi et al.[32] The criteria used for PCOS diagnosis were not specified in 4 studies.[19,23,33,34]
Participant populations were diverse, with some studies focusing exclusively on obese women, while others included participants with broader BMI ranges.
Two studies specifically evaluated nonoverweight and nonobese females.[35,36] All studies were of duration that lasted >2 weeks.
The interventions varied widely, encompassing dietary modifications, exercise programs, behavioral strategies, or combinations of these approaches, with durations ranging from 8 weeks to 12 months.
3.3. Characteristics of the interventions, outcomes, and findings
The characteristics of the interventions, results, and findings are illustrated in Table 2, which includes research with only dietary intervention (n = 4).[17,21,30,31] Dietary modifications with different compositions were used, such as low-calorie, low-fat diets as well as low- and high-protein diets. Despite these differences, however, certain trends and patterns have emerged. Dietary interventions are particularly effective in improving menstrual regularity, ovulation, and hormonal balance, with benefits closely tied to weight reduction and improved insulin sensitivity. A low-calorie diet with phased caloric restriction (330 kcal/d, followed by 1000 kcal/d) resulted in over 5% body weight loss (P < .001). This intervention improved menstruation and pregnancy rates, and significantly reduced testosterone levels (P < .01). Low-protein (55% carbohydrates) versus high-protein (40% carbohydrates) diets were tested for 16 weeks. Both led to improved menstrual regulation, pregnancy rates, and BMI reduction, with notable benefits in reproductive hormone profiles despite a dropout rate of 37.7%. A hypocaloric, high-protein diet achieved significant weight loss and improvements in reproductive function, including hormonal indices, within just 1 month.
Table 2.
Characteristics of the interventions, outcomes, and findings.
Study | Duration | Description of the intervention | Outcome | Dropout rate | Findings |
---|---|---|---|---|---|
Kiddy et al[21] | 7 mo | Low calorie: BMI > 30 kg/m2, 330 kcal/d for 4 wk, followed by a 1000 kcal/d for 6 mo, BMI = 25–30 kg/m2, 1000 kcal Low-fat diet, 20 g fat/d |
Clinical and biochemical indices of reproductive function | 0% | >5% loss of BW (P < .001), improvement in menstruation Pregnancy rate Reduction in testosterone (P < .01) |
Moran et al[30] | 16 wk | Low protein: 55% carbohydrate, 15% protein, and 30% fat High protein: 40% carbohydrate, 30% protein, and 30% fat |
BW, menstrual regulation, ovulation, hirsutism, and reproductive hormone profile | 37.7% | Improvement in menstruation Pregnancy rate Reduction of BMI |
Stamets et al[31] | 1 mo | High protein: 30% protein, 40% carbohydrate, and 30% fat or High carbohydrate:15% protein, 55% carbohydrate, and 30% fat |
BW hormonal indices of reproductive function | 25.7% | Significant weight loss and significant improvement in reproductive function in hypocaloric diet |
Bruner et al[41] | 12 wk | Endurance and resistance exercise plus nutritional counselling 3 d/wk. 10 min worm-up and 30 min exercise 1 hr/wk of nutritional counseling | Hormonal, menstrual, and reproductive function | 0 | Overall improvement in hormonal indices and menstruation |
Vigorito et al[25] | 3 mo | Training sessions 3 times/wk, 5-min warm up and cool down, and then 30-min exercise | Reproductive function; menses diary, and testosterone | 0 | 60% normal menstrual cycle Significant improvement of BMI and testosterone |
Thomson et al[26] | 20 wk | Energy-restricted, high-protein diet, and/or walking/jogging program 5 sessions/wk Exercise intensity progressed from 25 to 30 min during the first week to 45 min by study end |
Reproductive function | 44.6% | Significant improvement in BW, testosterone, and FAI (P < .001) and ovulation (49.1%) |
Palomba et al[22] | 24 wk | Three training session on a bicycle ergometer/30 min/3 times/wk. High-protein composition and restricted caloric diet |
Pregnancy rate, menstrual cycles, and fertility BMI |
15% | Both groups improve fertility |
Kordi et al[32] | Training session on a bicycle ergometer/30 min/3× /wk. 5-min warm up and 5-min cool down | Clinical symptoms and biochemical parameters | 0 | Significant reduction in ovarian volume and testosterone, and DHEA-S and SHBG levels | |
Nybacka et al[17] | 4 mo | Total daily caloric intake reduced by ≥600 kcal/d, while maintaining well-balanced diet endurance, aerobic, and/or weight training. | Ovarian function | 24.5% | BMI was reduced more. The menstrual pattern improved, and ovulation confirmed |
De Frène et al[24] | 24 wk | Thirty-minutes consultations calorie restriction of 450–850 kcal/d, counting the number of steps per day by means of a pedometer | BMI Quality of life |
25.8% | Overall increase in HRQoL Decrease of 5% in BMI |
Turan et al[35] | 8 wk | Structured exercise program each session 50 to 60 min, 3 times/wk | Menstrual cycle Total and free testosterone BMI |
12.5% | The mean menstrual cycle interval decreased significantly in the training group (P = .04) |
Almenning et al[37] | 10 wk | Three weekly exercise sessions. At least 1 session/wk was supervised by an exercise physiologist with normal diet | Testosterone, SHBG, and FAI BMI |
19.4% | Improvement of reproductive function |
Stefanaki et al[40] | 8 wk | Mindfulness stress management program, of a 30-min audio CD of directed mindfulness and diaphragmatic breathing exercises daily, before bedtime | BMI Quality of life: PCOSQ |
35% | DASS 21 depression (P = .011) and stress subscales (P = .025) |
Ramos et al[27] | 16 wk | Three series of 10 repetitions of each exercise for a period of 2 wk or 6 sessions of adaptation of 50 min | Testosterone level The SF-36 multidimensional questionnaire for quality of life |
24.2% | Significantly lower level of testosterone, no significant changes in BMI, significant improvement in the score for functional capacity |
Vizza et al[33] | 12 wk | Two supervised and 2 unsupervised (home-based) training sessions per week for 12 wk | Psychological Reproductive function and quality of life (PCOSQ) |
33.3% | No significant different in menstrual cycle between groups (P = .503). Significantly improvement 3 of 5 PCOSQ domain scores compared with SF-36 and DASS 21 |
Deepthi et al[19] | 8 wk | Walking and running on treadmill 3 sessions/wk, each lasting 45 min |
Quality of life, reducing BMI and number of follicles | 0% | Improved the quality of life by reducing the number of follicles and BMI |
Vasheghani-Farahani et al[38] | 12 wk | Walk with a medium intensity for 30 min/d, 5 d/wk | BMI Reproductive function |
25% | 4 women got pregnant and reduction of BMI not statistically significant |
Mani et al[28] | 12 mo | Seven hours of interactive discussions, including patient and professional story, diet and physical activity, balancing life with PCOS, and self-management | QoL PCOSQ and SF-12 Biochemical (testosterone) and BMI |
38% | Improved their QoL in 3 dimensions of PCOSQ and the SF-12 questionnaire; mean difference 5.79 (95% CI, 1.74–9.84; P = .006) |
Costa et al[20] | 16 wk | Progressive aerobic exercise for 40 min/d, 3 times/wk (≈150 min/wk) | Quality of life | 0 | HRQoL: physical functioning and mental health (P < .05) |
Oberg et al[18] | 4 mo | Group meetings 3× a month about; weight control, mindfulness, physical activity, and diet | Menstrual regularity and ovulation and pregnancy rates | 16% | Significant BMI reduction (P = .002), improved menstrual regularity, no difference in ovulation rate |
Cochrane et al[23] | 12 wk | Aerobic, aqua aerobic, and gym Sessions at least 2, 1 h sessions of supervised exercise classes |
BMI Menstrual regulation |
0% | BMI decreased significantly (P < .05), improvement in menstruation pattern |
Liu et al[29] | 8–12 gestational weeks to end of pregnancy | Diet and exercise guidance by a trained dietitian; 20–25 kcal/kg of was recommended Aerobic exercises 30 min/d, 5 d/wk |
Perinatal outcome Gestational weight gain |
66.4% | No difference in weight gain and neonatal outcomes; premature rupture of fetal membrane, fetal distress, and preterm delivery |
Benham et al[39] | 6 mo | Continuous aerobic exercise training High-intensity interval training |
Menstrual cycle, luteal phase length and numbers of ovulation events, pregnancies, and BMI | 21.6% | Better vaginal lubrication and overall sexual function 5 yr after the intervention |
D’souza et al[34] | 6 mo | Counseled for healthy diet based on the BMI, brisk walk, and jogging for 30 min. Core muscle exercises, each exercise performed for 20 min/d, 5 d/wk | Menstrual irregularities, clinical feature, and quality of life | Not mentioned | A significant improvement in the waist-hip ratio, hirsutism acne (P value < .001) and quality of life |
BMI = body mass index, BW = body weight, CD = compact disc, CI = confidence intervals, DASS 21 = Depression Anxiety Stress Scales, DHEA-S = Dehydroepiandrosterone sulfate, FAI = free androgen index, HRQoL = health-related quality of life, PCOS = polycystic ovary syndrome, PCOSQ = Polycystic Ovary Syndrome Questionnaire, QOL = quality of life, SF-36 = Short Form (36) Health Survey, SHBG = sex hormone binding globulin.
Exercise programs have also shown significant benefits, particularly structured aerobic or resistance training regimens. The efficacy of exercise alone was assessed in 11 studies.[19,20,22,25,27,32,33,35,37–39] Several structured training programs were followed, such as endurance and resistance exercises with low-, high-, and medium-intensity training. Exercise, particularly structured and supervised programs, improves reproductive function by reducing ovarian volume, lowering testosterone levels, and enhancing insulin sensitivity. A 3-month structured exercise program led to a 60% normalization of menstrual cycles and significant reductions in BMI and testosterone levels. The 8-week structured exercise program significantly reduced the mean menstrual cycle interval (P = .04), indicating improved menstrual regularity. A 6-month high-intensity interval training program improved menstrual cycle characteristics, including luteal phase length, ovulation events, and pregnancy rates, along with enhanced BMI reduction.
Behavioral and combined interventions offer a more holistic approach, targeting both the physical and psychological aspects of PCOS. Three studies used behavioral modification programs that included mindfulness stress management and nutritional counseling.[18,28,36] Behavioral interventions are highly effective in improving psychological well-being and quality of life, making them essential components of a holistic PCOS management plan. Mindfulness-based stress management programs reduced depression (P = .011) and stress (P = .025) while enhancing the overall quality of life.[40] The interventions in the remaining studies (n = 6) were applied using a combined approach, including either 2 or 3 interventions.[23,24,26,29,34,41] Studies integrating dietary, exercise, and behavioral components have demonstrated the most comprehensive improvements.[23,24,26,29,34,41]
The measured outcome was reproductive health in 16 studies, quality of life in 4 studies,[19,20,24,36] and another 4 studies evaluated the lifestyle intervention on reproductive health in addition to psychological and mental health and quality of life collectively.[27,28,33,34] Combined interventions address the multifactorial nature of PCOS, delivering improvements across reproductive, metabolic, and psychological domains, albeit with higher dropout rates in long-term programs.
The heterogeneity of the included studies underscores the need for individualized approaches to PCOS management. Differences in baseline participant characteristics, intervention protocols, and outcome measures suggest that a personalized strategy tailored to the unique needs of each patient may yield the best results. These findings highlight the importance of designing interventions that are both effective and adaptable to diverse presentations of PCOS.
3.4. Risk of bias
All included studies were evaluated for the quality of the methodology and risk of bias based on the Cochrane collaboration tool[42] that included selection bias (allocation concealment and random sequence generation), performance and detection bias, attrition and reporting bias, and any other type of bias that was not described in the above-mentioned types. The risk of bias is shown in Figure 2.[43]
Figure 2.
Risk of bias assessment of included studies using Cochrane Risk of Bias 2 (RoB 2) tool. This figure summarizes the assessment across 6 domains (D1–D6) for each study, where D1 represents allocation concealment, D2 represents random sequence generation, D3 represents blinding, D4 represents reporting bias, D5 represents attrition bias, and D6 represents other biases. Green circles indicate “low risk,” yellow circles indicate “some concerns,” and red circles indicate “high risk.”
Appropriate concealment of allocation of participants and random sequence generation were observed in 13 studies.[17,18,26,28–33,35,37,39,41] Vasheghani et al[38] reported that, despite the low risk of allocation concealment, the risk of random sequence generation was not clear. In contrast, it was not possible to determine from 2 trials whether adequate allocation concealment occurred, which could have led to selection bias.[25,34] Investigators described that a high risk of selection bias was described by the investigators[21,27] as a study design within group or without RCT, respectively. Palomba et al[22] reported that the allocation of interventions was based on participant preferences. Stefanaki et al[40] stated that no concealment was used within groups. Costa et al[20] could not randomize all participant allocation to exercise or control groups; Cochrane et al[23] stated “The subjects were not randomly assigned to groups,” while De Frène et al[24] used convenience sampling.
Due to the nature of the interventions, participants and investigators, in most of the research, were not blinded as it is not easy to blind the intervention group or the caregiver to exercise, diet, or behavioral interventions, which put them at an increased risk of performance and detection bias.
Good adherence with no dropout was reported in 5 studies.[19,20,23,25,32,41] The withdrawal rate was not mentioned in 1 study.[34] Kiddy et al[21] reported that, even though many participants missed follow-up, according to the author, their results were included in the report. Stefanaki et al[40] reported a withdrawal rate of 35% in the control group compared with 0% in the intervention group. A high drop rate of >25% was observed in 8 studies.[24,26,28,30,31,33,36,38] Liu et al[29] despite their application of messaging app (WeChat) to reduce dropouts and improve adherence to the program, had reported a very high noncompliant rate (66%) in the intervention group according to their definition per protocol of attending at least 7 sessions of the program. Another limitation is that the study depended on the participants’ self-report in determining the compliance rate. No reason was specified for this noncompliance.
For the remaining studies, the drop rate ranged from 12% to <25%.[17,18,22,27,35,37,39]
Reporting bias was demonstrated in 2 studies.[24,26] An increased number of missing data at different moments in time was reported by De Frène et al[24]. This was because of women who failed to complete the questionnaire and dropped from the trial. Thomson et al[26] published no conclusive findings regarding reproductive function.
Another type of bias reported by Cochrane et al,[23] was that the participants in the control group were significantly older than those in the intervention group (P < .05).
4. Discussion
This systematic review was conducted to establish the efficacy of lifestyle modifications (diet, exercise, and behavioral therapy in single or combined programs) in the management of PCOS while addressing the challenges and barriers to their implementation.
PCOS was diagnosed according to the Rotterdam criteria in most studies, which were used alone or in combination with other definitions, such as ESHRE/ASRM/NIH. The Rotterdam criteria are the most widely used categorization of PCOS worldwide according to international evidence-based recommendations, which endorse the use of Rotterdam criteria for the diagnosis of adult women with PCOS and the majority of studies and guidelines.[44] Obesity and PCOS have a powerful detrimental impact on reproductive, metabolic, and psychological health, posing serious public health concerns that necessitate both prevention and treatment. Seventy-five percent of thin women and 95% of overweight women have insulin resistance.[40] According to UK recommendations for the treatment of obese women with PCOS, weight management is recommended before starting ovarian stimulation therapy, preferably with a BMI of <30 kg/m2.[41]
Structured lifestyle intervention programs used in the management of PCOS, including exercise, diet, and behavioral management, either as monotherapy or in combination with 2 or 3 interventions, are considered the first-line nonpharmacological management strategy.[45]
Four studies in this review used dietary modifications alone to evaluate their effects on reproductive health.[17,21,30,31] These studies have focused on diet composition and weight loss in obese individuals; however, studies have addressed the effects of varying diet composition on the obese PCOS population. The underlying mechanisms of improved reproductive function in overweight/obese women with PCOS in these studies appeared to involve increased insulin sensitivity. Some of these studies have emphasized the importance of balanced diet control and weight loss, even in the short term. However, moderate weight loss during long-term calorie restriction is associated with marked clinical improvements in menstrual function and fertility. An energy deficit of 30% or 500 to 750 (1200–1500) kcal/d for women could be recommended to help overweight patients lose weight. Individualized energy needs, body weight, and exercise levels should also be considered.[46] Hypocaloric diets are advantageous in generating fast and significant weight loss, which plays a critical role in the amelioration of the PCOS phenotype, in addition to their role in improving insulin sensitivity and glycemic control. The efficacy of exercise alone was assessed in 10 studies included in this review.[19,20,22,25,27,32,33,35,37–39] Currently, the International Androgen Excess and PCOS Society strongly recommends regular exercise of ≥150 minutes per week to maintain good body health quality, with at least 90 minutes of moderate intensity exercise (heart rate, 150 times per minute), such as playing team sports such as football or basketball or brisk walking and running.[47] Regular exercise can help patients with PCOS and insulin resistance in 2 ways. First, patients with PCOS who regularly exercise can have reduced visceral fat, which subsequently leads to weight reduction. Visceral fat is more metabolically active and closely associated with insulin resistance. Second, exercise could control the activation of insulin signaling proteins in skeletal muscle, enhance muscle cell metabolism, and improve insulin sensitivity in patients with PCOS. Adults were advised to participate in muscle-strengthening activities on 2 separate days. Muscle-strengthening exercises should be minimally added to moderate-to-intense physical exercise 3 times per week.[47,48] Generally, it is recommended to reduce sedentary and inactivity duration. Although different studies suggest that exercise in combination with a hypocaloric diet has a stronger ability to enhance weight loss, regular exercise or physical activity is still regarded as helpful for women with PCOS.[49]
Twenty-two of the studies in the current review evaluated the effectiveness of lifestyle modifications in overweight and obese women with a BMI of ≥25 kg/m2 and the impact of weight reduction on reproductive health and patient psychological well-being and quality of life. Similarly, several studies have shown that weight loss can improve the fundamental phenotype of PCOS, lower circulating androgen levels, and cause spontaneous resumption of menses[15,18,23,24,28] and pregnancy; these findings are consistent with those of other studies.[47,48] These changes have been reported, even with a relatively modest weight loss of as little as 5% of the initial body weight.[14,18] Two studies in the current review evaluated the effect of exercise and behavioral lifestyle interventions, in nonoverweight and nonobese women, respectively, but using different outcomes. Turan et al[32] evaluated the efficacy of exercise on reproductive health and reported a significant improvement in menstrual cycle regulation in the training group (P = .04). Stefanaki et al,[40] who used quality of life as an outcome of endpoint measurement, found significant differences between the intervention and control groups in the depression subscales Depression Anxiety Stress Scales (P = .011) and stress (P = .025).
Three studies in this review used mindfulness stress management and nutritional counseling.[18,28,36] The integration of behavioral and psychological methods, such as setting objectives, self-monitoring, cognitive restructuring, problem resolution, and prevention of relapse, in weight control strategies for women with PCOS is likely to increase the program’s effectiveness. These drugs can be used to treat women with PCOS at various times during their reproductive lives.[47] Women with PCOS who participated in group training and counseling experienced improvements in weight and waist size.[44]
Behavioral management programs are essential treatment strategies for PCOS, and all healthcare providers should be aware of the need for counseling regarding PCOS management. Best patient counseling would result in improved overall treatment practice with the promotion of patient satisfaction. Six studies introduced a combined approach, including 2 or 3 interventions.[16,23,24,26,34,41] Combined dietary, physical activity, and behavioral and weight management are first-line therapy in international evidence-based guidelines for PCOS.[45] Furthermore, there is growing research on the potential benefits of including psychological and sleep interventions, as well as traditional or complementary approaches, for optimal management of PCOS.[4] However, there are many challenges in the application of evidence-based lifestyle changes at different levels, irrespective of the recommended guidelines. Setting SMART (Specific Measurable, Achievable, Realistic, and Timely) goals and keeping track of one’s progress might help attain realistic lifestyle objectives. Several barriers to lifestyle management appear to be common in different healthcare systems, exposing gaps in medical knowledge on how to integrate lifestyle management.[50] In general, many patients with PCOS express dissatisfaction with the advice given to them regarding lifestyle management. Insufficient communication between medical professionals creates difficulties in early diagnosis and treatment, limited utilization of allied health, a lack of follow-up and enforcement of intervention programs, and insufficient information delivery, all of which worsen patient satisfaction. Lathia et al[39] in their study related the poor adoption of an active lifestyle to inadequate information given to the patient, low self-confidence in addressing the problem, long duration and type of intervention used, and short consultation time.[44] The younger age of patients with PCOS appeared to be one of the factors associated with poor application of lifestyle changes in one study involved in this systematic review.[41] The researcher described taking care of small children, school, and work as difficulties in adhering to the exercise program. Others reported the place of living and nature of exercise as obstacles to poor adherence to the exercise program.[20,31] Stamets et al[31] also stated that failure to comply with the calorie restriction or type of diet used as a result of the improper implementation of the diet by participants was a common leading cause, particularly during the first week. Benham et al[39] related low exercise adherence to a lack of time, physical limitations, fear of injury, and lack of confidence. Pregnancy, illness, loss to follow-up, and personal issues, which are not specified, were additional barriers reported by 3 more studies involved in this systematic review.[27,30,37] Effective promotion of adherence requires individualizing the exercise in terms of form, intensity, duration, frequency, and demands and interests.
5. Strengths, limitations, and future directions
This systematic review has several strengths that enhance its value in the existing literature on PCOS management. By synthesizing evidence from 24 studies involving 1373 participants, this study provides a comprehensive overview of the impact of dietary, exercise, and behavioral interventions on reproductive, metabolic, and psychological outcomes. The inclusion of diverse interventions allows for a broader understanding of how various lifestyle modifications influence multifaceted health challenges associated with PCOS. Furthermore, the use of the Cochrane Risk of Bias 2 tool ensured a rigorous evaluation of the study quality, adding credibility to the findings. Another notable strength is the emphasis on real-world applicability, as the review highlights the effectiveness of nonpharmacological strategies, which are often preferred by patients and aligned with holistic care approaches.
Despite these strengths, this review has some limitations. The substantial heterogeneity among the included studies in terms of diagnostic criteria, intervention types, and outcome measures posed challenges to data synthesis and precluded the possibility of conducting a meta-analysis. Differences in participant characteristics, such as BMI ranges and baseline reproductive health, further limited the generalizability of the findings. Moreover, the variability in intervention duration, ranging from 8 weeks to 12 months, raises questions about the sustainability and long-term impact of the reported improvements.
Adherence to interventions has emerged as another concern, with several studies reporting high dropout rates, particularly for longer and more intensive programs. This inconsistency in compliance could have introduced a bias and influenced the reliability of the results. Furthermore, while reproductive and metabolic outcomes are commonly reported, psychological and quality-of-life measures are underrepresented, leaving a critical gap in understanding the broader benefits of lifestyle interventions. The lack of standardized tools for measuring these outcomes also complicates the comparisons across studies.
Future research should address these limitations by adopting standardized diagnostic criteria for PCOS and uniform protocols for interventions and outcome assessments. Long-term studies with extended follow-up periods are crucial to understand the sustainability of lifestyle interventions and their potential to prevent complications associated with PCOS. Given the heterogeneity of the syndrome, personalized intervention strategies that consider individual differences in age, BMI, insulin resistance, and psychological well-being are essential.
Expanding the scope of the research to include psychological and quality-of-life outcomes is equally important. Interventions targeting mental health and stress management should be integrated into future studies, with a focus on evaluating these aspects using validated tools, such as the Polycystic Ovary Syndrome Questionnaire or Short Form (36) Health Survey. In addition, exploring strategies to enhance adherence, such as incorporating digital health technologies, such as mobile apps and telemedicine, could improve the feasibility and effectiveness of lifestyle interventions.
Finally, the cost-effectiveness of these interventions warrants further investigation to inform healthcare policies and resource allocation. By addressing these areas, future research can build on the strengths of this review while overcoming its limitations, ultimately advancing the management of PCOS and improving the quality of life of women affected by this complex condition.
6. Conclusion
This systematic review highlights the efficacy of lifestyle interventions, including dietary, exercise, and behavioral strategies, in improving reproductive health, metabolic outcomes, psychological well-being, and quality of life in women with PCOS. Despite significant heterogeneity among the included studies, consistent trends demonstrated that weight reduction and improved insulin sensitivity are key predictors of positive outcomes. Dietary interventions, particularly low-calorie and high-protein diets, are effective in improving menstrual regularity, ovulation rates, and hormonal balance, whereas structured exercise programs contribute significantly to reducing BMI and androgen levels. Behavioral therapies, though less frequently studied, are promising in addressing the psychological dimensions of PCOS, such as depression and stress, thereby supporting a more comprehensive management approach.
However, the variability in study designs, populations, interventions, and outcome measures underscores the need for standardization in future research. Long-term studies with harmonized protocols and validated tools are essential to assess the sustainability of lifestyle intervention benefits and address underexplored areas such as psychological health and adherence challenges.
This review underscores the multifactorial nature of PCOS and the necessity of adopting personalized, integrative approaches for its management. Combining dietary, exercise, and behavioral interventions offers the greatest potential to address the complex and heterogeneous manifestations of PCOS. Future research should prioritize tailoring interventions to individual patient needs, ensure adherence, and expand the focus to include cost-effectiveness and long-term quality of life outcomes. These advancements will pave the way for more effective, evidence-based, and patient-centered management strategies for PCOS.
Acknowledgments
The authors express their sincere gratitude to all of those who supported and contributed to this study. The authors gratefully acknowledge funding from the Deanship of Graduate Studies and Scientific Research, Jazan University, Saudi Arabia, under Project Number GSSRD-24.
Author contributions
Conceptualization: Amal H. Mohamed, Osama Albasheer, Manar Ahmed Ghoniem, Nagla Abdalghani, Fatma Ayish, Siddig Ibrahim Abdelwahab, Maha Murtada Abdelmageed, Ahlam Mohammed S. Hakami, Ali Hassan Khormi, Ahmed Abdallah Altraifi, Isameldin Medani, Uma Chourasia, Suhaila A. Ali, Amani Abdelmola.
Data curation: Amal H. Mohamed, Osama Albasheer, Manar Ahmed Ghoniem, Nagla Abdalghani, Fatma Ayish, Siddig Ibrahim Abdelwahab, Maha Murtada Abdelmageed, Ahlam Mohammed S. Hakami, Ali Hassan Khormi, Ahmed Abdallah Altraifi, Isameldin Medani, Uma Chourasia, Suhaila A. Ali, Amani Abdelmola, Anas E. Ahmed.
Formal analysis: Amal H. Mohamed, Osama Albasheer, Manar Ahmed Ghoniem, Nagla Abdalghani, Fatma Ayish, Siddig Ibrahim Abdelwahab, Maha Murtada Abdelmageed, Ahlam Mohammed S. Hakami, Ali Hassan Khormi, Ahmed Abdallah Altraifi, Isameldin Medani, Uma Chourasia, Suhaila A. Ali, Amani Abdelmola, Anas E. Ahmed.
Funding acquisition: Amal H. Mohamed, Osama Albasheer, Manar Ahmed Ghoniem, Nagla Abdalghani, Fatma Ayish, Siddig Ibrahim Abdelwahab, Maha Murtada Abdelmageed, Ahlam Mohammed S. Hakami, Ali Hassan Khormi, Ahmed Abdallah Altraifi, Isameldin Medani, Uma Chourasia, Suhaila A. Ali, Amani Abdelmola, Anas E. Ahmed.
Investigation: Amal H. Mohamed, Osama Albasheer, Manar Ahmed Ghoniem, Nagla Abdalghani, Fatma Ayish, Siddig Ibrahim Abdelwahab, Maha Murtada Abdelmageed, Ahlam Mohammed S. Hakami, Ali Hassan Khormi, Ahmed Abdallah Altraifi, Isameldin Medani, Uma Chourasia, Suhaila A. Ali, Amani Abdelmola, Anas E. Ahmed.
Methodology: Amal H. Mohamed, Osama Albasheer, Manar Ahmed Ghoniem, Nagla Abdalghani, Fatma Ayish, Siddig Ibrahim Abdelwahab, Maha Murtada Abdelmageed, Ahlam Mohammed S. Hakami, Ali Hassan Khormi, Ahmed Abdallah Altraifi, Isameldin Medani, Uma Chourasia, Suhaila A. Ali, Amani Abdelmola, Anas E. Ahmed.
Project administration: Amal H. Mohamed, Osama Albasheer, Manar Ahmed Ghoniem, Nagla Abdalghani, Fatma Ayish, Siddig Ibrahim Abdelwahab, Maha Murtada Abdelmageed, Ahlam Mohammed S. Hakami, Ali Hassan Khormi, Ahmed Abdallah Altraifi, Isameldin Medani, Uma Chourasia, Suhaila A. Ali, Amani Abdelmola, Anas E. Ahmed.
Resources: Amal H. Mohamed, Osama Albasheer, Manar Ahmed Ghoniem, Nagla Abdalghani, Fatma Ayish, Siddig Ibrahim Abdelwahab, Maha Murtada Abdelmageed, Ahlam Mohammed S. Hakami, Ali Hassan Khormi, Ahmed Abdallah Altraifi, Isameldin Medani, Uma Chourasia, Suhaila A. Ali, Amani Abdelmola, Anas E. Ahmed.
Software: Amal H. Mohamed, Osama Albasheer, Manar Ahmed Ghoniem, Nagla Abdalghani, Fatma Ayish, Siddig Ibrahim Abdelwahab, Maha Murtada Abdelmageed, Ahlam Mohammed S. Hakami, Ali Hassan Khormi, Ahmed Abdallah Altraifi, Isameldin Medani, Uma Chourasia, Suhaila A. Ali, Amani Abdelmola, Anas E. Ahmed.
Supervision: Amal H. Mohamed, Osama Albasheer, Manar Ahmed Ghoniem, Nagla Abdalghani, Fatma Ayish, Siddig Ibrahim Abdelwahab, Maha Murtada Abdelmageed, Ahlam Mohammed S. Hakami, Ali Hassan Khormi, Ahmed Abdallah Altraifi, Isameldin Medani, Uma Chourasia, Suhaila A. Ali, Amani Abdelmola, Anas E. Ahmed.
Validation: Amal H. Mohamed, Osama Albasheer, Manar Ahmed Ghoniem, Nagla Abdalghani, Fatma Ayish, Siddig Ibrahim Abdelwahab, Maha Murtada Abdelmageed, Ahlam Mohammed S. Hakami, Ali Hassan Khormi, Ahmed Abdallah Altraifi, Isameldin Medani, Uma Chourasia, Suhaila A. Ali, Amani Abdelmola, Anas E. Ahmed.
Visualization: Amal H. Mohamed, Osama Albasheer, Manar Ahmed Ghoniem, Nagla Abdalghani, Fatma Ayish, Siddig Ibrahim Abdelwahab, Maha Murtada Abdelmageed, Ahlam Mohammed S. Hakami, Ali Hassan Khormi, Ahmed Abdallah Altraifi, Isameldin Medani, Uma Chourasia, Suhaila A. Ali, Amani Abdelmola, Anas E. Ahmed.
Writing – original draft: Amal H. Mohamed, Osama Albasheer, Manar Ahmed Ghoniem, Nagla Abdalghani, Fatma Ayish, Siddig Ibrahim Abdelwahab, Maha Murtada Abdelmageed, Ahlam Mohammed S. Hakami, Ali Hassan Khormi, Ahmed Abdallah Altraifi, Isameldin Medani, Uma Chourasia, Suhaila A. Ali, Amani Abdelmola, Anas E. Ahmed.
Writing – review & editing: Amal H. Mohamed, Osama Albasheer, Manar Ahmed Ghoniem, Nagla Abdalghani, Fatma Ayish, Siddig Ibrahim Abdelwahab, Maha Murtada Abdelmageed, Ahlam Mohammed S. Hakami, Ali Hassan Khormi, Ahmed Abdallah Altraifi, Isameldin Medani, Uma Chourasia, Suhaila A. Ali, Amani Abdelmola, Anas E. Ahmed.
Abbreviations:
- ASRM
- American Society of Reproductive Medicine
- BMI
- body mass index
- DASS 21
- Depression Anxiety Stress Scales
- ESHRE
- European Society of Human Reproduction and Embryology
- NIH
- National Institutes of Health
- PCOS
- polycystic ovary syndrome
- PCOSQ
- Polycystic Ovary Syndrome Questionnaire
- RCT
- randomized controlled trial
- SF-36
- Short Form (36) Health Survey
- USG
- ultrasound sonography.
This project is funded by the Deanship of Graduate Studies and Scientific Research, Jazan University, Saudi Arabia, under Project Number GSSRD-24.
The authors have no conflicts of interest to disclose.
The datasets generated during and/or analyzed during the current study are available from the corresponding author upon reasonable request.
How to cite this article: Mohamed AH, Albasheer O, Ghoniem MA, Abdalghani N, Ayish F, Abdelwahab SI, Abdelmageed MM, Hakami AMS, Khormi AH, Altraifi AA, Medani I, Chourasia U, Ali SA, Abdelmola A, Ahmed AE. Impact of lifestyle interventions on reproductive and psychological outcomes in women with polycystic ovary syndrome: A systematic review. Medicine 2025;104:3(e41178).
Contributor Information
Amal H. Mohamed, Email: aalkhair@jazanu.edu.sa.
Manar Ahmed Ghoniem, Email: dmamm.nour@gmail.com.
Nagla Abdalghani, Email: nabdalghani@jazanu.edu.sa.
Fatma Ayish, Email: fayish@jazanu.edu.sa.
Siddig Ibrahim Abdelwahab, Email: sadiqa@jazanu.edu.sa.
Maha Murtada Abdelmageed, Email: mmurtada@jazanu.edu.sa.
Ahlam Mohammed S. Hakami, Email: ahlamhakami@jazanu.edu.sa.
Ali Hassan Khormi, Email: alikhormi@jazanu.edu.sa.
Ahmed Abdallah Altraifi, Email: aaltraifi@jazanu.edu.sa.
Isameldin Medani, Email: iemedani@jazanu.edu.sa.
Uma Chourasia, Email: uchourasia@jazanu.edu.sa.
Suhaila A. Ali, Email: suali@jazanu.edu.sa.
Amani Abdelmola, Email: aabashar@jazanu.edu.sa.
Anas E. Ahmed, Email: aeahmed@jazanu.edu.sa.
References
- [1].Zehravi M, Maqbool M, Ara I. Polycystic ovary syndrome and reproductive health of women: a curious association. Int J Adolesc Med Health. 2021;33:333–7. [DOI] [PubMed] [Google Scholar]
- [2].Ding H, Zhang J, Zhang F, et al. Resistance to the insulin and elevated level of androgen: a major cause of polycystic ovary syndrome. Front Endocrinol. 2021;12:741764. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [3].Damone AL, Joham AE, Loxton D, Earnest A, Teede HJ, Moran LJ. Depression, anxiety and perceived stress in women with and without PCOS: a community-based study. Psychol Med. 2019;49:1510–20. [DOI] [PubMed] [Google Scholar]
- [4].Cowan S, Lim S, Alycia C, et al. Lifestyle management in polycystic ovary syndrome–beyond diet and physical activity. BMC Endocr Disord. 2023;23:14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5].Yazici H, Taskin MI, Guney G, Hismiogullari AA, Arslan E, Tulaci KG. The novel relationship between polycystic ovary syndrome and temporomandibular joint disorders. J Stomatol Oral Maxillofac Surg. 2021;122:544–8. [DOI] [PubMed] [Google Scholar]
- [6].Guney G, Taşkin MI, Sener N, et al. The role of ERK-1 and ERK-2 gene polymorphisms in PCOS pathogenesis. Reprod Biol Endocrinol. 2022;20:95. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7].Camili FE, Akis M, Adali E, et al. Oncostatin M is related to polycystic ovary syndrome-case control study. Biomedicines. 2024;12:355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [8].Parker J, O’brien C, Hawrelak J, Gersh FL. Polycystic ovary syndrome: an evolutionary adaptation to lifestyle and the environment. Int J Environ Res Public Health. 2022;19:1336. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [9].Tokmak A, Guzel AI, Güney G, Tasdemir U, Umit C, Yilmaz N. Effect of obesity on clinical parameters and pregnancy rates in women with polycystic ovary syndrome undergoing ovulation induction cycles. J Reprod Med. 2017;62:300–4. [PubMed] [Google Scholar]
- [10].Domecq JP, Prutsky G, Mullan RJ, et al. Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis. J Clin Endocrinol Metab. 2013;98:4655–63. [DOI] [PubMed] [Google Scholar]
- [11].Adullhameed SM, Abdelhafez AA, ElAzab DR, Alseraty WH. Effect of lifestyle changes intervention on quality of life and self-esteem of adolescent female with polycystic ovary syndrome. Int Egypt J Nurs Sci Res. 2022;2:524–33. [Google Scholar]
- [12].Dietz de Loos A, Jiskoot G, Beerthuizen A, Busschbach J, Laven J. Metabolic health during a randomized controlled lifestyle intervention in women with PCOS. Eur J Endocrinol. 2022;186:53–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [13].Abdolahian S, Tehrani FR, Amiri M, et al. Effect of lifestyle modifications on anthropometric, clinical, and biochemical parameters in adolescent girls with polycystic ovary syndrome: a systematic review and meta-analysis. BMC Endocr Disord. 2020;20:1–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [14].Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [15].Sterne JA, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366. doi: 10.1136/bmj.l4898. [DOI] [PubMed] [Google Scholar]
- [16].Yu F, Liu C, Sharmin S. Performance, usability, and user experience of Rayyan for systematic reviews. Proc Assoc Inf Sci Technol. 2022;59:843–4. [Google Scholar]
- [17].Nybacka A, Carlström K, Ståhle A, Nyrén S, Hellström PM, Hirschberg AL. Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome. Fertil Steril. 2011;96:1508–13. [DOI] [PubMed] [Google Scholar]
- [18].Oberg E, Gidlöf S, Jakson I, Mitsell M, Tollet Egnell P, Hirschberg AL. Improved menstrual function in obese women with polycystic ovary syndrome after behavioural modification intervention—a randomized controlled trial. Clin Endocrinol (Oxf). 2019;90:468–78. [DOI] [PubMed] [Google Scholar]
- [19].Deepthi G, Sankarakumaran P, Jerome A, Kalirathinam D, Raj NB, US MR. Effect of aerobic exercise in improving the quality of life in polycystic ovarian disease. Res J Pharm Technol. 2017;10:1788–90. [Google Scholar]
- [20].Costa EC, Sá JCFd, Stepto NK, et al. Aerobic training improves quality of life in women with polycystic ovary syndrome. 2018. [DOI] [PubMed]
- [21].Kiddy DS, Hamilton‐Fairley D, Bush A, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 1992;36:105–11. [DOI] [PubMed] [Google Scholar]
- [22].Palomba S, Falbo A, Zullo F, Orio F. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr Rev. 2009;30:1–50. [DOI] [PubMed] [Google Scholar]
- [23].Cochrane T, Tengku-Kamalden TF, Davey R, Omar Dev RD. Effect of exercise and weight loss in polycystic ovarian syndrome among obese women. Pertanika J Soc Sci Humanit. 2021;29:29. [Google Scholar]
- [24].De Frène V, Verhofstadt L, Lammertyn J, Stuyver I, Buysse A, De Sutter P. Quality of life and body mass index in overweight adult women with polycystic ovary syndrome during a lifestyle modification program. J Obstet Gynecol Neonatal Nurs. 2015;44:587–99. [DOI] [PubMed] [Google Scholar]
- [25].Vigorito C, Giallauria F, Palomba S, et al. Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007;92:1379–84. [DOI] [PubMed] [Google Scholar]
- [26].Thomson RL, Buckley JD, Noakes M, Clifton PM, Norman RJ, Brinkworth GD. The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93:3373–80. [DOI] [PubMed] [Google Scholar]
- [27].Ramos FKP, Da Silva Lara LA, Kogure GS, et al. Quality of life in women with polycystic ovary syndrome after a program of resistance exercise training. Rev Bras Ginecol Obstet. 2016;38:340–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [28].Mani H, Chudasama Y, Hadjiconstantinou M, et al. Structured education programme for women with polycystic ovary syndrome: a randomised controlled trial. Endocr Connect. 2018;7:26–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [29].Liu C, Zhang L, Zheng W, et al. Lifestyle intervention for overweight/obese pregnant women with polycystic ovarian syndrome: lessons and challenges. Obes Facts. 2021;14:405–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [30].Moran LJ, Deeks A, Gibson-Helm M, et al. Psychological parameters in the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod. 2012;27:2082–8. [DOI] [PubMed] [Google Scholar]
- [31].Stamets K, Taylor DS, Kunselman A, Demers LM, Pelkman CL, Legro RS. A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome. Fertil Steril. 2004;81:630–7. [DOI] [PubMed] [Google Scholar]
- [32].Kordi MR, Motie Z, Amirsasan R, et al. Effects of aerobic training on clinical symptoms and biochemical parameters in women with polycystic ovarian syndrome. Int J Adva Sci Res Rev. 2011;1:01–5. [Google Scholar]
- [33].Vizza L, Smith CA, Swaraj S, Agho K, Cheema BS. The feasibility of progressive resistance training in women with polycystic ovary syndrome: a pilot randomized controlled trial. BMC Sports Sci Med Rehabil. 2016;8:1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [34].D’souza P, Rodrigues DE, Kaipangala RG, et al. Effectiveness of multimodular interventions of lifestyle modification on symptoms of polycystic ovarian syndrome and quality of life among women-a quasi-experimental study. J Clin Diagn Res. 2022;16:308. [Google Scholar]
- [35].Turan V, Mutlu EK, Solmaz U, et al. Benefits of short-term structured exercise in non-overweight women with polycystic ovary syndrome: a prospective randomized controlled study. J Phys Ther Sci. 2015;27:2293–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [36].Barber TM, Hanson P, Weickert MO, Franks S. Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies. Clin Med Insights Reprod Health. 2019;13:1179558119874042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [37].Almenning I, Rieber-Mohn A, Lundgren KM, Shetelig Løvvik T, Garnæs KK, Moholdt T. Effects of high intensity interval training and strength training on metabolic, cardiovascular and hormonal outcomes in women with polycystic ovary syndrome: a pilot study. PLoS One. 2015;10:e0138793. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [38].Vasheghani-Farahani F, Khosravi S, Yekta AHA, et al. The effect of home based exercise on treatment of women with poly cystic ovary syndrome; a single-blind randomized controlled trial. Novelty Biomed. 2017;5. [Google Scholar]
- [39].Benham JL, Booth JE, Corenblum B, et al. Exercise training and reproductive outcomes in women with polycystic ovary syndrome: a pilot randomized controlled trial. Clin Endocrinol (Oxf). 2021;95:332–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [40].Stefanaki C, Bacopoulou F, Livadas S, et al. Impact of a mindfulness stress management program on stress, anxiety, depression and quality of life in women with polycystic ovary syndrome: a randomized controlled trial. Stress. 2015;18:57–66. [DOI] [PubMed] [Google Scholar]
- [41].Bruner B, Chad K, Chizen D. Effects of exercise and nutritional counseling in women with polycystic ovary syndrome. Appl Physiol Nutr Metab. 2006;31:384–91. [DOI] [PubMed] [Google Scholar]
- [42].Higgins JP, Altman DG, Gøtzsche PC, et al. ; Cochrane Bias Methods Group. The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [43].McGuinness LA, Higgins JP. Risk‐of‐bias visualization (robvis): an R package and Shiny web app for visualizing risk‐of‐bias assessments. Res Synth Methods. 2021;12:55–61. [DOI] [PubMed] [Google Scholar]
- [44].Lathia T, Joshi A, Behl A, et al. A practitioner’s toolkit for polycystic ovary syndrome counselling. Indian J Endocrinol Metab. 2022;26:17–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [45].Neven ACH, Laven J, Teede HJ, Boyle JA. A summary on polycystic ovary syndrome: diagnostic criteria, prevalence, clinical manifestations, and management according to the latest international guidelines. Semin Reprod Med. 2018;36:5–12. [DOI] [PubMed] [Google Scholar]
- [46].Teede HJ, Joham AE, Paul E, et al. Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women. Obesity (Silver Spring). 2013;21:1526–32. [DOI] [PubMed] [Google Scholar]
- [47].Teede HJ, Misso ML, Deeks AA, et al. ; Guideline Development Groups. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust. 2011;195:S65–112. [DOI] [PubMed] [Google Scholar]
- [48].Wang S, Zhang Z, Liu Y. Effects of exercise intervention on the improvement of polycystic ovary syndrome. Polycystic Ovarian Syndrome: IntechOpen; 2019. [Google Scholar]
- [49].Woodward A, Klonizakis M, Broom D. Exercise and polycystic ovary syndrome. Phys Exercise Hum Health. 2020;1228:123–36. [DOI] [PubMed] [Google Scholar]
- [50].Blackshaw LC, Chhour I, Stepto NK, et al. Barriers and facilitators to the implementation of evidence-based lifestyle management in polycystic ovary syndrome: a narrative review. Med Sci. 2019;7:76. [DOI] [PMC free article] [PubMed] [Google Scholar]